Related Experiment Videos
Synthesis of a sequence-specific DNA-cleaving peptide
J P Sluka1, S J Horvath, M F Bruist
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena 91125.
Summary
Researchers created a hybrid peptide that binds specific DNA sequences and cleaves them. This synthetic molecule, combining Hin recombinase DNA-binding and ethylenediaminetetraacetic acid (EDTA) cleavage domains, offers a novel tool for DNA manipulation.
Area of Science:
- Molecular Biology
- Biochemistry
- Synthetic Chemistry
Background:
- Hin recombinase is a key enzyme in DNA recombination.
- Sequence-specific DNA binding is crucial for targeted genetic manipulation.
- Ethylenediaminetetraacetic acid (EDTA) can be used for DNA cleavage in the presence of metal ions.
Purpose of the Study:
- To construct a hybrid peptide with both DNA-binding and DNA-cleavage capabilities.
- To investigate the DNA-binding mode of the synthetic peptide.
- To demonstrate a novel approach for creating targeted DNA-modifying agents.
Main Methods:
- Synthesizing a 52-residue peptide based on the Hin recombinase DNA-binding domain (residues 139-190).
- Conjugating ethylenediaminetetraacetic acid (EDTA) to the peptide's amino terminus.
- Performing DNA cleavage assays using the synthetic EDTA-peptide in the presence of Fe(II) at Hin recombination sites.
Main Results:
- The synthetic EDTA-peptide successfully cleaved DNA at specific Hin recombination sites.
- DNA cleavage data indicated that the peptide's amino terminus binds to the minor groove of DNA near the recombination site's symmetry axis.
- The study successfully demonstrated the fusion of sequence-specific DNA binding and DNA cleavage functions into a single hybrid molecule.
Conclusions:
- A novel hybrid peptide combining sequence-specific DNA binding and EDTA-mediated DNA cleavage has been successfully constructed.
- The synthetic peptide binds to the minor groove of DNA at Hin recombination sites, enabling targeted cleavage.
- This work presents a promising strategy for developing engineered nucleases and tools for precise DNA manipulation.